Following the development of progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis (MS) patients treated with natalizumab and interferon-beta (IFNbeta), a possible correlation between JC virus (JCV), the etiological agent of PML, and MS has received heightened interest. In particular, attention has focused on assessing whether IFNbeta treatment could affect the replication of JCV and thus its frequency in the peripheral blood of MS patients and whether the presence of JCV DNA in peripheral blood could be a predictive marker of the risk of developing PML. In order to answer to these questions, peripheral blood samples were collected from 59 INFbeta-treated, 39 untreated relapsing-remitting MS patients, and 98 healthy controls (HCs) and JCV DNA levels were determined and quantified by means of a real-time polymerase chain reaction (Q-PCR) assay. Overall, no differences were found in the presence or viral load of JCV DNA of MS patients and the HCs, but JCV DNA was significantly less frequent in the peripheral blood of IFNbeta-treated patients (13.6%) compared to the untreated MS patients (46.1%) and the healthy controls (28.6%). These results suggest that the presence of JCV in the blood of MS patients cannot be considered as a marker or a risk factor for PML development. In addition, they indicate that treatment with INFbeta can lead to the reduction of presence of the JCV genome in the peripheral blood of MS patients and, thus, that this drug probably does not increase the risk of PML in MS patients treated with IFNbeta.

JC virus viremia in interferon-beta-treated and untreated Italian multiple sclerosis patients and healthy controls / S. Delbue, F.R. Guerini, R. Mancuso, D. Caputo, R. Mazziotti, M. Saresella, P. Ferrante. - In: JOURNAL OF NEUROVIROLOGY. - ISSN 1355-0284. - 13:1(2007), pp. 73-77.

JC virus viremia in interferon-beta-treated and untreated Italian multiple sclerosis patients and healthy controls

S. Delbue
Primo
;
P. Ferrante
Ultimo
2007

Abstract

Following the development of progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis (MS) patients treated with natalizumab and interferon-beta (IFNbeta), a possible correlation between JC virus (JCV), the etiological agent of PML, and MS has received heightened interest. In particular, attention has focused on assessing whether IFNbeta treatment could affect the replication of JCV and thus its frequency in the peripheral blood of MS patients and whether the presence of JCV DNA in peripheral blood could be a predictive marker of the risk of developing PML. In order to answer to these questions, peripheral blood samples were collected from 59 INFbeta-treated, 39 untreated relapsing-remitting MS patients, and 98 healthy controls (HCs) and JCV DNA levels were determined and quantified by means of a real-time polymerase chain reaction (Q-PCR) assay. Overall, no differences were found in the presence or viral load of JCV DNA of MS patients and the HCs, but JCV DNA was significantly less frequent in the peripheral blood of IFNbeta-treated patients (13.6%) compared to the untreated MS patients (46.1%) and the healthy controls (28.6%). These results suggest that the presence of JCV in the blood of MS patients cannot be considered as a marker or a risk factor for PML development. In addition, they indicate that treatment with INFbeta can lead to the reduction of presence of the JCV genome in the peripheral blood of MS patients and, thus, that this drug probably does not increase the risk of PML in MS patients treated with IFNbeta.
English
Settore MED/07 - Microbiologia e Microbiologia Clinica
Articolo
Sì, ma tipo non specificato
2007
Taylor & Francis
13
1
73
77
Periodico con rilevanza internazionale
info:eu-repo/semantics/article
JC virus viremia in interferon-beta-treated and untreated Italian multiple sclerosis patients and healthy controls / S. Delbue, F.R. Guerini, R. Mancuso, D. Caputo, R. Mazziotti, M. Saresella, P. Ferrante. - In: JOURNAL OF NEUROVIROLOGY. - ISSN 1355-0284. - 13:1(2007), pp. 73-77.
none
Prodotti della ricerca::01 - Articolo su periodico
7
262
Article (author)
si
S. Delbue, F.R. Guerini, R. Mancuso, D. Caputo, R. Mazziotti, M. Saresella, P. Ferrante
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/43287
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 28
social impact